BBC News

People coming off weight-loss injections risk fast weight gain

Forbes

World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know

SpringerLink

Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain

News Medical

Stopping weight loss drugs leads to rapid weight regain and health reversal

Bmj.R2586

University of Oxford

New study finds that stopping weight-loss drugs is linked to faster regain than ending diet programmes

Off-label GLP-1 use highlights the cultural pressures driving body anxieties

Independent

Why losing three stone made me more miserable than I was before

Guardian

Thursday briefing: Why skinny jabs short-term fix comes with long-term concerns

Pubmed

Even with diet and exercise, Ozempic use reduces perceived effort and praiseworthiness of resulting weight loss

The Telegraph

Slim Jab Users Gain Weight Four Times Faster Other Dieters

The Times

Weight-loss jab users pile pounds on much faster when they stop

WHO issues global guideline on the use of GLP-1 medicines in treating obesity

Bmj 2025 085304

JAMA Network

2841273

The Sun

Scientists finally discover how long it takes before the weight starts piling back on after stopping fat jabs

People regained weight, worsened heart health after stopping weight loss drugs: review

Daily Mail

Take fat jabs for life, experts rule - as pivotal study reveals users coming off the drugs pile the pounds back on in under two years

Healthcare Management

Patients on weight-loss injections 'regain weight faster' than other dieters

EuroNews

People regain weight within two years of coming off obesity drugs, new study finds

Daily Record

People who stop weight loss jags regain weight four times faster than dieters

RTE.ie

People who stop slimming jabs regain weight within 2 yrs

People on fat loss jabs ‘put weight back on faster than traditional dieters’

People.com

People Who Stop Taking Weight-Loss Medications Regain Weight Within 2 Years, Study Says

Hellorayo

Weight Loss Jabs Rapid Regain Study

Youtube

- YouTube

Research published in the British Medical Journal analyzed 37 studies involving more than 9,000 participants and found that people using weight management medications regained an average of 0.4 kg per month after stopping treatment. The study projected that users would return to their pre-treatment weight within approximately 1.7 years.

Research published in the British Medical Journal analyzed 37 studies involving more than 9,000 participants and found that people using weight management medications regained an average of 0.4 kg per month after stopping treatment. The study projected that users would return to their pre-treatment weight within approximately 1.7 years.

The research examined GLP-1 receptor agonist medications including semaglutide, sold under brand names Wegovy and Ozempic, and tirzepatide, sold under brand names Mounjaro and Zepbound. Only eight of the 37 studies assessed treatment with these newer GLP-1 drugs, with a maximum follow-up period of one year after medication stopped.

The research examined GLP-1 receptor agonist medications including semaglutide, sold under brand names Wegovy and Ozempic, and tirzepatide, sold under brand names Mounjaro and Zepbound. Only eight of the 37 studies assessed treatment with these newer GLP-1 drugs, with a maximum follow-up period of one year after medication stopped.

The study found that all cardiometabolic markers, including blood sugar levels, cholesterol and blood pressure, were projected to return to baseline within 1.4 years after cessation of weight management medications. These health benefits paralleled weight changes and were lost as weight was regained.

The study found that all cardiometabolic markers, including blood sugar levels, cholesterol and blood pressure, were projected to return to baseline within 1.4 years after cessation of weight management medications. These health benefits paralleled weight changes and were lost as weight was regained.

Under current NHS policy, Wegovy can only be prescribed for a maximum of two years, while there is no specified time limit for Mounjaro prescriptions. A spokesperson for Eli Lilly stated that weight return after stopping treatment reflects the biology of obesity rather than a lack of effort.

Under current NHS policy, Wegovy can only be prescribed for a maximum of two years, while there is no specified time limit for Mounjaro prescriptions. A spokesperson for Eli Lilly stated that weight return after stopping treatment reflects the biology of obesity rather than a lack of effort.

Weight Loss Drug Users Regain Weight Within 2 Years: Study

SlimmingWeight jabsLoss Drug Users Regain Weight Within 2 Years: Study

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Weight Loss Drug Users Regain Weight Within 2 Years: Study

SlimmingWeight jabsLoss Drug Users Regain Weight Within 2 Years: Study

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters